Table I.
Group | Sample size | Survival time (days)
|
|
---|---|---|---|
Mean (±SD) | MST | ||
Control | 6 | 84.50±5.65 | 87 |
Celecoxib | 6 | 104.00±5.40a | 96.5 |
SC-560 | 6 | 99.67±3.91a | 97 |
SC-560+celecoxib | 6 | 94.83±5.47 | 93 |
Indomethacin | 6 | 97.67±3.55 | 95.5 |
Statistical significance was determined using the Dunnett’s test.
P<0.05. MST, median survival time.